| Name | Title | Contact Details |
|---|
Pella Regional Health Center is a critical access hospital in central Iowa with integrated family practice, internal medicine providers as well as general surgeons and gynecologists. Pella Regional has medical clinics in five communities (Pella, Knoxville, Monroe, Sully and Bussey) and outpatient services like Hospice of Pella and Home Health Care that extend well beyond the walls of the hospital. In addition a new clinic was added in Ottumwa in Fall 2012, and an occupational health clinic opened in Newton in Spring 2012.
Jeffrey J Eckardt is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At UnitedHealthcare we`re dedicated to helping people live healthier lives and helping to make the health system work better for everyone by simplifying the health care experience, meeting consumer health needs and sustaining trusted relationships with care providers. These are extraordinary times in health care. The opportunities to help people live healthier have never been greater. Advanced data and technologies, breakthrough treatments and consumer choice are redefining what can be achieved. At UnitedHealthcare, part of the UnitedHealth Group family of businesses, we are working to create a system that is connected, aligned and more affordable for all involved; one that delivers high quality care, responsive to the needs of each person and the communities in which they live. With connections to more than 1.3 million physicians and care professionals and 6,200+ hospitals and care facilities across the globe, we can collaborate in new ways to improve patient care while providing customizable and comprehensive solutions in any market place, anywhere. Our Values Integrity: Honor commitments. Never compromise ethics. Compassion: Walk in the shoes of people we serve and those with whom we work. Relationships: Build trust through collaboration. Innovation: Invent the future, learn from the past. Performance: Demonstrate excellence in everything we do.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Health Media Lab is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.